355 related articles for article (PubMed ID: 20655243)
41. Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women.
Hershman DL; Wang X; McBride R; Jacobson JS; Grann VR; Neugut AI
Breast Cancer Res Treat; 2006 Oct; 99(3):313-21. PubMed ID: 16583264
[TBL] [Abstract][Full Text] [Related]
42. Radical cystectomy in the elderly: Comparison of survival between younger and older patients.
Clark PE; Stein JP; Groshen SG; Cai J; Miranda G; Lieskovsky G; Skinner DG
Cancer; 2005 Feb; 103(3):546-52. PubMed ID: 15630702
[TBL] [Abstract][Full Text] [Related]
43. New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients.
Ryberg M; Nielsen D; Cortese G; Nielsen G; Skovsgaard T; Andersen PK
J Natl Cancer Inst; 2008 Aug; 100(15):1058-67. PubMed ID: 18664656
[TBL] [Abstract][Full Text] [Related]
44. [The use of adjuvant chemotherapy in stage II breast cancer in the last 25 years--a brief review].
Sulkes A
Harefuah; 2002 Apr; 141(4):374-8, 408. PubMed ID: 12017895
[TBL] [Abstract][Full Text] [Related]
45. Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: results from the OMEGA study of the Dutch breast cancer trialists' group.
Hamaker ME; Seynaeve C; Wymenga AN; van Tinteren H; Nortier JW; Maartense E; de Graaf H; de Jongh FE; Braun JJ; Los M; Schrama JG; van Leeuwen-Stok AE; de Groot SM; Smorenburg CH
Breast; 2014 Feb; 23(1):81-7. PubMed ID: 24314824
[TBL] [Abstract][Full Text] [Related]
46. Adjuvant chemotherapy for stage III colon cancer in the oldest old: results beyond clinical guidelines.
Abraham A; Habermann EB; Rothenberger DA; Kwaan M; Weinberg AD; Parsons HM; Gupta P; Al-Refaie WB
Cancer; 2013 Jan; 119(2):395-403. PubMed ID: 22806931
[TBL] [Abstract][Full Text] [Related]
47. Geriatric Assessment Predicts Survival and Competing Mortality in Elderly Patients with Early Colorectal Cancer: Can It Help in Adjuvant Therapy Decision-Making?
Antonio M; Saldaña J; Carmona-Bayonas A; Navarro V; Tebé C; Nadal M; Formiga F; Salazar R; Borràs JM
Oncologist; 2017 Aug; 22(8):934-943. PubMed ID: 28487465
[TBL] [Abstract][Full Text] [Related]
48. Adjuvant docetaxel/cyclophosphamide in breast cancer patients over the age of 70: results of an observational study.
Freyer G; Campone M; Peron J; Facchini T; Terret C; Berdah JF; Jacquin JP; Coeffic D; Hilaire Pde S; Falandry C
Crit Rev Oncol Hematol; 2011 Dec; 80(3):466-73. PubMed ID: 21565521
[TBL] [Abstract][Full Text] [Related]
49. Adjuvant chemotherapy of breast cancer in the older patient.
Taylor WC; Muss HB
Oncology (Williston Park); 2010 Jun; 24(7):608-13. PubMed ID: 20669797
[TBL] [Abstract][Full Text] [Related]
50. Comprehensive geriatric assessment in 326 older women with early breast cancer.
Okonji DO; Sinha R; Phillips I; Fatz D; Ring A
Br J Cancer; 2017 Sep; 117(7):925-931. PubMed ID: 28797032
[TBL] [Abstract][Full Text] [Related]
51. Relative dose intensity in early stage breast cancer chemotherapy: A retrospective analysis of incidence, risk factors and outcomes at a south-west Sydney cancer clinic.
Sandy J; Della-Fiorentina S
Asia Pac J Clin Oncol; 2013 Dec; 9(4):365-72. PubMed ID: 23937317
[TBL] [Abstract][Full Text] [Related]
52. Breast cancer in the elderly: which lessons have we learned?
Turner N; Zafarana E; Becheri D; Mottino G; Biganzoli L
Future Oncol; 2013 Dec; 9(12):1871-81. PubMed ID: 24295417
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of the costs and resource use associated with adjuvant chemotherapy for breast cancer in France.
Laas E; Vataire AL; Aballea S; Valentine W; Gligorov J; Chereau E; Rouzier R
J Med Econ; 2012; 15(6):1167-75. PubMed ID: 22853442
[TBL] [Abstract][Full Text] [Related]
54. Adjuvant systemic treatment for elderly breast cancer patients; addressing safety concerns.
Abdel-Rahman O; ElHalawani H
Expert Opin Drug Saf; 2014 Nov; 13(11):1443-67. PubMed ID: 25244502
[TBL] [Abstract][Full Text] [Related]
55. [Influence of clinical and biographical factors on the delay in starting adjuvant chemotherapy treatment among breast cancer patients].
Baena-Cañada JM; Rosado-Varela P; Estalella-Mendoza S; Expósito-Álvarez I; González-Guerrero M; Benítez-Rodríguez E
Med Clin (Barc); 2013 May; 140(10):444-8. PubMed ID: 22613828
[TBL] [Abstract][Full Text] [Related]
56. A population-based study on the implementation of treatment recommendations for chemotherapy in early breast cancer.
Joerger M; Thürlimann B; Savidan A; Frick H; Bouchardy C; Konzelmann I; Probst-Hensch N; Ess S
Clin Breast Cancer; 2012 Apr; 12(2):102-9. PubMed ID: 22138066
[TBL] [Abstract][Full Text] [Related]
57. Population-based assessment of emergency room visits and hospitalizations among women receiving adjuvant chemotherapy for early breast cancer.
Enright K; Grunfeld E; Yun L; Moineddin R; Ghannam M; Dent S; Eisen A; Trudeau M; Kaizer L; Earle C; Krzyzanowska MK
J Oncol Pract; 2015 Mar; 11(2):126-32. PubMed ID: 25604597
[TBL] [Abstract][Full Text] [Related]
58. Factors Predicting Adherence to a Tailored-Dose Adjuvant Treatment on the Basis of Geriatric Assessment in Elderly People With Colorectal Cancer: A Prospective Study.
Antonio M; Carmona-Bayonas A; Saldaña J; Navarro V; Tebé C; Salazar R; Borràs JM
Clin Colorectal Cancer; 2018 Mar; 17(1):e59-e68. PubMed ID: 29054805
[TBL] [Abstract][Full Text] [Related]
59. Associated factors and outcomes of delaying adjuvant chemotherapy in breast cancer by biologic subtypes: a National Cancer Database study.
Ashok Kumar P; Paulraj S; Wang D; Huang D; Sivapiragasam A
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2447-2458. PubMed ID: 33517468
[TBL] [Abstract][Full Text] [Related]
60. Relative dose intensity--improving treatment and outcomes in early-stage breast cancer: a retrospective study.
Griffin DA; Penprase B; Klamerus JF
Oncol Nurs Forum; 2012 Nov; 39(6):E459-67. PubMed ID: 23107859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
